Endowments provide faculty with freedom and flexibility to pursue critical research endeavors
Aug. 14, 2018
| By Kristen Woodward / Fred Hutch News Service
Hematologist Dr. Geoffrey Hill, a physician-scientist who was recently recruited from Australia to lead Hematopoietic Stem Cell Transplantation at Fred Hutch, is the third and most recent recipient of the José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research.
She plans to use the funds to develop new surveillance and diagnostic strategies for immunotherapy trials
Aug. 8, 2018
| By Colin Petersdorf / Fred Hutch News Service
Fred Hutchinson Cancer Research Center biostatistician Dr. Yingqi Zhao has been awarded the Dr. Charles A. Coltman Jr. Fellowship, which recognizes and funds prolific early- and mid-career scientists from affiliated institutions within SWOG, a national clinical trials network.
Scientists aim to gather knowledge that improves future immunotherapies
July 30, 2018
| By Susan Keown / Fred Hutch News Service
The immune system has the potential to eradicate cancer. But cancers are expert escape artists, with numerous tools for shutting down or hiding from immune attack. Three research teams at Fred Hutch have launched new projects aimed at revealing some of these secrets and laying the groundwork for developing better immune-harnessing cancer therapies, or immunotherapies.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.